§01 Browse › Cabergoline

Cabergoline

Caber Dostinex Cabaser

None

Technical catalog description

Cabergoline is a dopamine agonist primarily used to control prolactin levels during cycles containing compounds with progestogenic activity such as trenbolone, nandrolone, or trestolone.

Elevated prolactin can cause gynecomastia, sexual dysfunction, and mood issues. Cabergoline effectively reduces prolactin levels and can improve libido, mood, and overall well-being. Many users report enhanced mood and motivation when using cabergoline.

Overview Use context Comparison Safety
Warning
Very expensive medication · Only use if prolactin elevation confirmed by blood work · Can cause nausea when starting - take with food · May cause compulsive behaviors in rare cases

Read next

The Philosophy and Practice of Harm Reduction 9 min read
More depthAdvanced Ancillary ManagementAdvanced Labs InterpretationInteraction Risks and Common Escalation Mistakes
Overview
Mechanism details

Cabergoline is a dopamine D2 receptor agonist used to reduce elevated prolactin levels. Its primary role in the performance context is managing prolactin-related side effects from 19-nor compounds (Trenbolone, Nandrolone, Trestolone) that have progestogenic activity and can drive prolactin elevation.

Elevated prolactin in men causes lactation from nipple tissue (galactorrhea), sexual dysfunction (anorgasmia, inability to maintain erection), reduced libido, and mood disruption. These symptoms are frequently misattributed to estrogen or other hormonal issues before prolactin is measured.

When to use it: The decision to use cabergoline should be based on measured prolactin, not on compound reputation. Many users on Trenbolone or Nandrolone cycles maintain prolactin within normal range. Running cabergoline prophylactically without confirmed elevation adds dopaminergic drug exposure without clear benefit.

This profile does not establish a starting amount, repeat-administration frequency, or titration protocol. A reported half-life alone cannot supply those missing references.

Safety & monitoring
Side effects

  • Nausea, dizziness, low blood pressure, and compulsive behavior in susceptible users

  • Mood swings if prolactin is pushed too low

Monitoring

  • prolactin

  • blood pressure

  • behavioral or psychiatric changes

Avoid if

  • Unexplained psychiatric symptoms, impulse-control issues, or valvular heart disease history

  • Using it without confirming that prolactin is truly the problem

Use context

Cabergoline is effective when the diagnosis is correct: confirmed hyperprolactinemia with associated symptoms. In this setting, the response can be dramatic, sexual function, libido, and mood often improve substantially within 1–2 weeks.

Timeline & expectations

Prolactin begins falling within days of first dose. Symptomatic improvement typically follows within 1–2 weeks if prolactin was the primary driver. If symptoms do not improve, other causes should be investigated rather than escalating cabergoline dose.

Common mistakes

Adding cabergoline preemptively to every 19-nor cycle regardless of measured prolactin. This exposes the user to dopaminergic side effects (nausea, dizziness, hypotension, and in rare cases compulsive behaviors) without clear indication.

Using cabergoline without first checking whether estrogen is the actual driver of nipple-related symptoms. High estrogen is more common than high prolactin as a cause of gynecomastia sensitivity on most cycles. Lab-first approach prevents misdiagnosis.

Running too high a dose for too long. Prolactin below normal range is not harmless; it can cause low mood, motivation problems, and reduced sex drive in its own right.

Comparison notes

This catalog does not establish a cabergoline amount that offsets adverse effects from another compound. Community descriptions of managing symptoms are not a validated combination regimen.

Record quantities in the builder Read: The Philosophy and Practice of Harm Reduction ← Browse